Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs.
about
Special considerations in the treatment of patients with bipolar disorder and medical co-morbiditiesStatins and its hepatic effects: Newer data, implications, and changing recommendationsEvaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicityMetformin and metabolic diseases: a focus on hepatic aspectsHepato-biliary late effects in survivors of childhood and adolescent cancer: a report from the Children's Oncology GroupReview article: prescribing medications in patients with cirrhosis - a practical guide.FXR antagonism of NSAIDs contributes to drug-induced liver injury identified by systems pharmacology approach.Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasisDifficulty with diagnosis of malignant pancreatic neoplasms coexisting with chronic pancreatitisClinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4.Effects of statins on cholestasis: good, bad or indifferent?Diabetes and Hepatitis C: A Two-Way Association.Drug bioactivation, covalent binding to target proteins and toxicity relevance.Do preclinical testing strategies help predict human hepatotoxic potentials?Lipid-lowering agents that cause drug-induced hepatotoxicity.The safety of rosuvastatin: effects on renal and hepatic function.Improved Insulin Resistance and Lipid Metabolism by Cinnamon Extract through Activation of Peroxisome Proliferator-Activated Receptors.Simvastatin Reduces Capsular Fibrosis around Silicone Implants.Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group.Clopidogrel-induced hepatocellular injury and cholestatic jaundice in an elderly patient: case report and review of the literature.Application of mechanism-based CYP inhibition for predicting drug-drug interactions.Hepatotoxicity related to antirheumatic drugs.Metabolic syndrome and bipolar disorder: what should psychiatrists know?Application of in vivo metabolomics to preclinical/toxicological studies: case study on phenytoin-induced systemic toxicity.Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review.Evaluation of antidiabetic activity of biologically synthesized silver nanoparticles using Pouteria sapota in streptozotocin-induced diabetic rats.Ursolic acid derivatives for pharmaceutical use: a patent review (2012-2016).Proteasome inhibitors, including curcumin, improve pancreatic β-cell function and insulin sensitivity in diabetic mice.Effect of combined therapy of diabinese and nicotinic acid on liver enzymes in rabbits with dithizone-induced diabetes.Hepatitis following famotidine: a case report.Mitigation of statins-induced cytotoxicity and mitochondrial dysfunction by L-carnitine in freshly-isolated rat hepatocytes.Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?Biochemical mechanisms in drug-induced liver injury: certainties and doubts.The effect of antiepileptic drugs on mitochondrial activity: a pilot study.Drug-induced liver injury: is it somehow foreseeable?Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles.Signaling pathways involved in induction of GADD45 gene expression and apoptosis by troglitazone in human MCF-7 breast carcinoma cells.Sirolimus-associated hepatotoxicity in liver transplantation.Effects of a novel formulation of essential oils on glucose-insulin metabolism in diabetic and hypertensive rats: a pilot study.[The PRISCUS list in clinical routine. Practicability and comparison to international PIM lists].
P2860
Q24806762-3200E0B7-2251-4770-AECD-5F87786483F6Q26767065-011E2227-BCA4-4067-96A1-6F2C3112FDEEQ27027301-6A5A18C7-B172-44F2-AC66-7FAF5455B78DQ28082736-CA22CB23-85AA-43CB-81E7-3692BE921A51Q33729370-4CA6D393-9B8A-41ED-A1FA-8A4A7CF9ABCAQ34342554-250B4269-3CB7-4B34-918D-F9B4C9E2E51EQ35025312-A000BF9B-51D4-413B-9612-BA93327FE436Q35064467-FA7E8795-314E-4519-816A-F9B5E452FC35Q35064548-AD3B2BA6-65C0-4689-8C86-62C21FAA9752Q35166632-9B9D50E3-5D41-417A-8503-B0C7D2DE31DDQ35275494-6E7A2B6B-5C6B-4E04-A5B7-16A61026D36CQ36056076-799B7C48-572A-4A24-BE78-0C1F31704D8DQ36061821-9B8DFB39-11E6-4807-AD66-33BAF56F2496Q36086429-B3C9B36D-A1B1-46FF-BC4A-E20A4B3514B7Q36103339-9C8E46A1-6170-4E42-A660-EBBA0EEEDF5EQ36945023-38021452-5F8B-4953-9405-28F381017419Q37014815-6B563D45-D7F9-4131-AF31-9662FF9C7A84Q37110500-8C839E28-954C-4B9F-A2FE-AD5223DDC6C2Q37142641-461DC721-5DAA-4DC6-A564-64A27D7E4B47Q37461447-BD6FFFA1-CBB3-40C6-8DBD-0E48647E4851Q37494640-3365AB80-CA87-4DE6-BEAA-9E78B3EAFDCBQ37832129-DA473ACA-877F-4B76-A93C-8B493F43A207Q37954425-5C24DD0A-454E-4A14-871A-420E6207B597Q38050517-0AC6F7CD-9D8B-4041-89E5-DEE6E0B4FFC7Q38132123-6948DF89-635A-496E-876C-08A1BC883DD0Q38742311-658BF4B7-102D-4602-94F8-6D4F39ACC980Q39388546-C6A5FCDC-8F5B-4E3E-8E57-BC13F5293E0DQ40945955-DC62252B-2A73-4366-BCEE-4F9A2246EBAEQ41350580-06D3991B-F6E8-4924-806B-827D5AAC9E6DQ41985310-AE1D9C5D-14D8-4FEA-9BAE-0BC345EDAA91Q42187203-DD2D9149-D7A3-419D-8B79-542BDA3A7577Q42333984-1F870AF0-D8CB-4918-87DD-FB8AA5DDB9C9Q42588200-9340AC96-3FD0-4157-8F50-1B034431B934Q43088233-3C091457-0EBF-4B78-BD54-EDCCF00F7CD2Q43109156-91E79B40-3B47-478D-A637-D190B9E2F5C4Q44590836-60E851F4-A378-4920-9B62-A09DA552A7C1Q44830451-30C437E2-C0F6-44D2-8F4F-08ACB59C87E6Q45029808-3FF35D64-2466-4170-A254-5B739282C543Q45269431-1CB7BDA0-25BF-4B6E-B6FD-DC3CEB102060Q45802705-324E8413-1690-4115-9A57-147AB2E631DA
P2860
Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Hepatotoxicity of commonly use ...... ng agents, psychotropic drugs.
@ast
Hepatotoxicity of commonly use ...... ng agents, psychotropic drugs.
@en
Hepatotoxicity of commonly use ...... ng agents, psychotropic drugs.
@nl
type
label
Hepatotoxicity of commonly use ...... ng agents, psychotropic drugs.
@ast
Hepatotoxicity of commonly use ...... ng agents, psychotropic drugs.
@en
Hepatotoxicity of commonly use ...... ng agents, psychotropic drugs.
@nl
prefLabel
Hepatotoxicity of commonly use ...... ng agents, psychotropic drugs.
@ast
Hepatotoxicity of commonly use ...... ng agents, psychotropic drugs.
@en
Hepatotoxicity of commonly use ...... ng agents, psychotropic drugs.
@nl
P356
P1476
Hepatotoxicity of commonly use ...... ing agents, psychotropic drugs
@en
P2093
Jacob George
P304
P356
10.1055/S-2002-30102
P577
2002-01-01T00:00:00Z